Jounce Therapeutics Inc (JNCE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2022 | 09-2022 | 06-2022 | 03-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 150,572 | 77,111 | 77,741 | 60,412 | 95,529 |
| Marketable Securities | 38,970 | 51,498 | 70,823 | 95,006 | 83,037 |
| TOTAL | $197,231 | $139,930 | $157,347 | $164,836 | $190,827 |
| Non-Current Assets | |||||
| PPE Net | 3,721 | 3,926 | 4,406 | 4,449 | 4,882 |
| Investments And Advances | 0 | 1,723 | 13,691 | 30,977 | 41,657 |
| Other Non-Current Assets | 11,598 | 12,502 | 13,457 | 14,409 | 15,330 |
| TOTAL | $15,319 | $18,151 | $31,554 | $49,835 | $61,869 |
| Total Assets | $212,550 | $158,081 | $188,901 | $214,671 | $252,696 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,095 | 1,115 | 3,439 | 1,903 | 1,674 |
| Accrued Expenses | 17,145 | 16,604 | 15,801 | 10,962 | 13,467 |
| Other current liabilities | 178 | 54 | 43 | 35 | 62 |
| TOTAL | $23,568 | $21,797 | $23,195 | $16,702 | $18,898 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 5,870 | 6,926 | 7,976 | 9,006 | 9,993 |
| TOTAL | $5,870 | $6,926 | $7,976 | $9,006 | $9,993 |
| Total Liabilities | $29,438 | $28,723 | $31,171 | $25,708 | $28,891 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 52,140 | 51,694 | 51,694 | 51,674 | 51,665 |
| Common Shares | 51 | 51 | 51 | 51 | 51 |
| Retained earnings | -292,792 | -343,751 | -312,753 | -279,240 | -241,873 |
| Other shareholders' equity | -677 | -1,031 | -1,097 | -901 | -238 |
| TOTAL | $183,112 | $129,358 | $157,730 | $188,963 | $223,805 |
| Total Liabilities And Equity | $212,550 | $158,081 | $188,901 | $214,671 | $252,696 |